More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake.

Sweeney, Sedona; Singh, Maninder Pal; (2022) More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake. The Lancet Global Health, 11 (2). e183-e184. DOI: https://doi.org/10.1016/S2214-109X(22)00519-8

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S2214-109X(22)00519-8

Abstract

Share

Download

Published Version Download

Filename: Sweeny_Singh_2022_More-treatment-options-for-rifampicin-resistant.pdf

Licence: Creative Commons: Attribution 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar

Google Scholar
Report this Record Edit item (admin only) View this record in elements